Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3KEJ

Crystal Structure of Human MMP-13 complexed with a (pyridin-4-yl)-2H-tetrazole compound

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeSYNCHROTRON
Source detailsAPS BEAMLINE 17-ID
Synchrotron siteAPS
Beamline17-ID
Temperature [K]110
Detector technologyCCD
Collection date2005-06-12
DetectorADSC QUANTUM 210
Wavelength(s)1.0
Spacegroup nameP 21 21 2
Unit cell lengths120.883, 96.457, 36.638
Unit cell angles90.00, 90.00, 90.00
Refinement procedure
Resolution29.800 - 2.300
R-factor0.18602
Rwork0.183
R-free0.23611
Structure solution methodFOURIER SYNTHESIS
RMSD bond length0.009
RMSD bond angle1.153
Data reduction softwareHKL-2000
Data scaling softwareHKL-2000
Phasing softwareMOLREP
Refinement softwareREFMAC (5.2.0019)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]30.0002.280
High resolution limit [Å]2.2002.200
Rmerge0.1120.370
Number of reflections22451
<I/σ(I)>14.54.4
Completeness [%]100.096.3
Redundancy4.83.4
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, SITTING DROP8277Protein: 5.5 mg/ml MMP-13 with 200 uM surrogate inhibitor in 20mM Tris pH 8.5 and 5 mM CaCl2. reservoir: 1.1-1.6M Li2SO4 in 0.1M Hepes pH 7.4-8.2. drop ratio: 5ul protein + 1 ul reservoir., VAPOR DIFFUSION, SITTING DROP, temperature 277K

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon